Shafia Rahman

Aug 4, 2023 | mdpi.com | Andrew J. Gunderson |Shafia Rahman |Jordan M. Cloyd |Robert Connor Chick

Abstract: Simple SummaryPancreatic cancer is a deadly disease with limited effective treatments. Despite growing interest in immunotherapy for other cancer types, immunotherapy has not shown significant utility in metastatic pancreatic cancer. However, investigators are examining the role of immunotherapy in the preoperative setting in order to prime the immune system to detect and prevent micrometastatic disease and recurrence.